SELECT MEDICAL HOLDINGS CORP (SEM) Forecast, Price Target & Analyst Ratings
NYSE:SEM • US81619Q1058
16.25 USD
0 (0%)
At close: Mar 6, 2026
16.25 USD
0 (0%)
After Hours: 3/6/2026, 8:04:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SELECT MEDICAL HOLDINGS CORP (SEM).
Forecast Snapshot
Consensus Price Target
$17.88
+ 10.06% Upside
Next Earnings Forecast
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate$0.47
Revenue Estimate1.425B
ChartMill Buy Consensus
77.78%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$17.88
Upside
+ 10.06%
From current price of $16.25 to mean target of $17.88, Based on 9 analyst forecasts
Low
$16.16
Median
$17.34
High
$21.00
Price Target Revisions
1 Month
-3.49%
3 Months
-3.49%
Price Target Summary
9 analysts have analysed SEM and the average price target is 17.88 USD. This implies a price increase of 10.06% is expected in the next year compared to the current price of 16.25.
The average price target has been revised downward by 3.49% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
77.78%
SEM was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about SEM.
In the previous month the buy percentage consensus was at a similar level.
SEM was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-04 | Benchmark | Downgrade | Buy -> Hold |
| 2026-03-03 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2026-02-23 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-04 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-02-24 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-01-03 | UBS | Maintains | Neutral -> Neutral |
| 2024-11-25 | Benchmark | Downgrade | Buy -> Hold |
| 2024-11-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-04 | Benchmark | Reiterate | Buy -> Buy |
| 2024-11-01 | Benchmark | Reiterate | Buy -> Buy |
| 2024-09-06 | Benchmark | Reiterate | Buy -> Buy |
| 2024-08-20 | B of A Securities | Reiterate | Buy |
| 2024-08-05 | Benchmark | Reiterate | Buy -> Buy |
| 2024-08-02 | Benchmark | Reiterate | Buy -> Buy |
| 2024-07-16 | Benchmark | Maintains | Buy -> Buy |
| 2024-05-06 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-05-06 | Benchmark | Maintains | Buy -> Buy |
| 2024-05-03 | Benchmark | Reiterate | Buy -> Buy |
| 2024-04-12 | Benchmark | Reiterate | Buy -> Buy |
| 2023-11-30 | UBS | Initiate | Neutral |
| 2023-11-08 | Benchmark | Reiterate | Buy -> Buy |
| 2023-08-07 | Credit Suisse | Maintains | Neutral -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate$0.47
Revenue Estimate1.425B
Revenue Q2Q5.31%
EPS Q2Q6.00%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
-0.21%
Revenue (3 Months)
-0.21%
EPS (1 Month)
4.58%
EPS (3 Months)
4.58%
Next Earnings Summary
SEM is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is 0.47 USD and the consensus revenue estimate is 1.43B USD.
The next earnings revenue estimate has been revised downward by 0.21% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.826B 4.70% | 5.187B 7.48% | 5.453B 5.12% | 5.75B 5.45% | 6.025B 4.78% | 6.293B 4.45% | |
| EBITDA YoY % growth | 475.984M 35.77% | 472.209M -0.79% | 476.473M 0.90% | 538.14M 12.94% | 579.78M 7.74% | 626.77M 8.10% | |
| EBIT YoY % growth | 267.242M 84.62% | 268.315M 0.40% | 336.17M 25.29% | 380.79M 13.27% | 420.87M 10.53% | 468.08M 11.22% | |
| Operating Margin | 5.54% | 5.17% | 6.17% | 6.62% | 6.99% | 7.44% | |
| EPS YoY % growth | 1.99 61.79% | 1.65 -17.09% | 1.15 -30.30% | 1.31 13.52% | 1.42 8.92% | 1.45 2.22% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.47 6.00% | 0.30 -4.74% | 0.23 -1.90% | 0.33 103.58% | 0.48 2.86% | 0.35 16.30% | 0.26 16.83% | 0.38 16.74% |
| Revenue Q2Q % growth | 1.425B 5.31% | 1.413B 5.48% | 1.425B 4.51% | 1.446B 3.53% | 1.505B 5.61% | 1.487B 5.24% | 1.499B 5.19% | 1.532B 5.95% |
| EBITDA Q2Q % growth | 154.86M 4.95% | 129.52M -17.07% | 120.23M -32.09% | 141.69M -30.63% | 168.89M 9.06% | 142.58M 10.08% | 132.35M 10.08% | 153.68M 8.46% |
| EBIT Q2Q % growth | 116.57M 3.39% | 90.942M 5.10% | 80.378M 10.17% | 97.558M 52.59% | 127.17M 9.09% | 99.01M 8.87% | 94.218M 17.22% | 107.33M 10.02% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.64%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
18.69%
EBIT Next 5 Year
N/A
SELECT MEDICAL HOLDINGS CORP / SEM Forecast FAQ
Can you provide the average price target for SELECT MEDICAL HOLDINGS CORP stock?
9 analysts have analysed SEM and the average price target is 17.88 USD. This implies a price increase of 10.06% is expected in the next year compared to the current price of 16.25.
What is the next earnings date for SEM stock?
SELECT MEDICAL HOLDINGS CORP (SEM) will report earnings on 2026-04-29, after the market close.
Can you provide the consensus estimates for SELECT MEDICAL HOLDINGS CORP next earnings?
The consensus EPS estimate for the next earnings of SELECT MEDICAL HOLDINGS CORP (SEM) is 0.47 USD and the consensus revenue estimate is 1.43B USD.
Can you provide the analyst count for SELECT MEDICAL HOLDINGS CORP stock?
The number of analysts covering SELECT MEDICAL HOLDINGS CORP (SEM) is 9.